Skip to content
Search

Latest Stories

Man jailed for robbing pharmacy at knifepoint

While none of the pharmacy staff were physically harmed, they were left deeply shake following the incident

Man jailed for robbing pharmacy at knifepoint

Daniel Bennett threatened to harm staff unless medication was handed over.

Avon and Somerset Police

A man who robbed a pharmacy in Winterbourne last year at knifepoint has been sentenced to prison.

Daniel Bennett, 41 of Wedmore Vale in Bedminster, was jailed for six years and nine months, with an extended three-year licence period, after pleading guilty to robbery and possession of a bladed article.


Bristol Crown Court heard that Bennett entered the pharmacy in Winterbourne on 8 August last year armed with a knife and forced staff to the rear of the store, threatening to harm them unless they handed over medication.

After obtaining the drugs, he fled in a car driven by Natasha O’Driscoll, 34, of Old Gloucester Road, Winterbourne. A child was also in the vehicle, leaning out of the passenger window.

O’Driscoll pleaded guilty to assisting an offender and neglect of a child under 16. She was sentenced to a 12-month community order and fined.

Avon and Somerset Police responded swiftly and stopped O’Driscoll. They found a large amount of prescription drugs in her car, but Bennett was not with her.

Following further enquiries, officers found him in a nearby pub car park, still in possession of a knife and prescription drugs.

While none of the pharmacy staff were physically harmed, they were "understandably shaken by what happened", according to a statement from the police.

One of the victims who managed to escape and alert the police described the traumatic experience.

“I was on my lunch break when I heard the commotion,” the victim recalled.

“I grabbed my bag and phone and walked behind the guy who was holding my colleagues at knifepoint. I made it out and called the police.”

“I stayed in work until the following Thursday but I had to take time off work due to lack of sleep, because I was getting flashbacks to what happened.

“This is not something any of us will be able to get over. We feel unsafe and I will always be looking over my shoulder.”

DC Craig Bennett, the investigating officer, described Bennett’s actions that day were “reckless and dangerous.”

“He appeared to give no thought for how his behaviour would harm those around him, he was focused on stealing those prescription drugs for his own benefit,” he said.

“The victims have been left feeling vulnerable and fearful following the incident and I have to commend them for the strength they have shown in supporting our investigation.

“O’Driscoll acted as the getaway driver for Bennett’s scheme, but she not only endangered her own life, but also that of a child’s,” he added.

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less